Effect of inhaler corticosteroid in chronic lung disease
Phase 3
- Conditions
- Chronic Obstructive Pulmonary Disease.Chronic obstructive pulmonary disease, unspecified
- Registration Number
- IRCT20181126041758N1
- Lead Sponsor
- Zahedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 65
Inclusion Criteria
New patient with COPD diagnosis according history and spiromerty data, that was without exacerbation during last 4 week,
Exclusion Criteria
Cardiovascular disease
Hematologic-oncologic disorder
Collagen vascular disease
COPD exacerbation during last 4 weeks
Use of corticosteroid for ohter cause
parasitic infection
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change the distance traveled within 6 minutes on a 30-meter interval after 3 months use of inhalation corticosteroids. Timepoint: At first visit and after 3 month. Method of measurement: 6 minute walking test.
- Secondary Outcome Measures
Name Time Method